Zimmer Biomet (NYSE:ZBH) is opening a new office location in Fairfield, Conn., the hometown of its recently appointed CEO Bryan Hanson, according to a CTPost report. The location will served as an “East Coast hub” for Hanson and other executives in the area, according to the report, and will serve as the second New York City-area […]
FDA releases Zimmer Biomet warning letter
The FDA yesterday released the warning letter it sent last week to Zimmer Biomet (NYSE:ZBH)over quality violations found during 2016 and 2018 inspections at a plant in Warsaw, Ind. Zimmer revealed its receipt of the August 24 letter earlier this week, saying it doesn’t expect to take a material hit from resolving the issues flagged in the […]
Zimmer Biomet reveals FDA warning letter for Indiana plant
Zimmer Biomet (NYSE:ZBH) today said it received a warning letter last week from the FDA about a plant in its home base of Warsaw, Ind., over quality violations found during a 2016 inspection. The FDA inspected the North Campus location in Warsaw just before Thanksgiving 2016, documenting numerous violations in a Form 483. The company’s lengthy […]
KFx inks Zimmer licensing deal, sues Stryker over patent infringement
KFx Medical said yesterday it inked a licensing agreement with Zimmer Biomet (NYSE:ZBH) for patents used in knotless double row rotator cuff repair and that it filed a lawsuit against Stryker (NYSE:SYK) which it claims infringes on patents also related to knotless double row rotator cuff repair. Through the licensing agreement, Zimmer Biomet and its affiliates will have the […]
Judge tosses Zimmer Biomet hip suit over statute of limitations issues
A US District Judge for the Pennsylvania Federal Court yesterday dismissed a plaintiff’s claims of injury related to a Zimmer Biomet (NYSE:ZBH) metal-on-metal prosthetic hip because it passed the statute of limitations. Plaintiff Marilyn Adams was implanted with a Zimmer hip prosthesis in 2011, and claimed to suffer pain and complications for years after. She underwent […]
Zimmer Biomet shares rise on Street-beating Q2
Shares in Zimmer Biomet (NYSE:ZBH) rose today after the medical device maker posted second quarter earnings that topped expectations on Wall Street. The Warsaw, Ind.-based company posted profits of $184.9 million, or 90¢ per share, on sales of $2 billion for the three months ended June 30, for bottom-line growth of 0.4% while sales grew 3% […]
NinePoint Medical lifts Namati to the corner office | Personnel Moves – July 10, 2018
NinePoint Medical said earlier this month that it appointed Eman Namati as its new president and chief executive officer, succeeding Christopher von Jako who will remain on the company’s board of directors. Namati joined NinePoint Medical at its inception in 2010 as a technical co-founder, and operated as R&D VP for the past four years, […]
Argus downgrades Zimmer Biomet
Declining sales and the supply & manufacturing issues that have bedeviled Zimmer Biomet (NYSE:ZBH) recently prompted an Argus analyst to downgrade the orthopedic giant’s stock today. Argus analyst David Toung moved ZBH shares from a “buy” to a “hold” rating based on the company’s estimate that it would be the second quarter before it returned to full […]
Zimmer Biomet ends BoneSupport Cerament BVF distribution deal
BoneSupport said today that its US exclusive distributor Zimmer Biomet (NYSE:ZBH) has cancelled the majority of its orders for Cerament bone void filler for a three month period starting in June. The move comes after the Sweden-based orthobiologic producer announced plans to develop its own US-based distribution network, which includes cancelling its distribution agreement with Zimmer Biomet. “Today’s […]
FDA clears Zimmer Biomet’s 3D-printed titanium Zyston spinal implant
Zimmer Biomet (NYSE:ZBH) said yesterday it won FDA 510(k) clearance for its Zyston Strut open titanium interbody spacer system, touting it as the company’s first 3D-printed titanium spinal implant. The Zyston Strut open titanium system is a family of lumbar cages intended to enhance strength, graft capacity and visualization capabilities of interbody spacers in spinal fusion […]
Stryker’s Howmedica owes $13m in fees in Zimmer Biomet patent spat
Stryker‘s (NYSE:SYK) Homedica is on the hook for approximately $13.3 million in attorney’s fees and $513,258 in costs due to Zimmer Biomet (NYSE:ZBH) as a result of a patent dispute, according to recently unsealed court documents. The award is the result of a long-running patent spat over polymers between the two companies that ended in four […]
- 1
- 2
- 3
- …
- 34
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+